These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 33242463)
1. HIF1α promotes tumor chemoresistance via recruiting GDF15-producing TAMs in colorectal cancer. Zheng H; Yu S; Zhu C; Guo T; Liu F; Xu Y Exp Cell Res; 2021 Jan; 398(2):112394. PubMed ID: 33242463 [TBL] [Abstract][Full Text] [Related]
2. Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer. Yu S; Li Q; Yu Y; Cui Y; Li W; Liu T; Liu F Cancer Immunol Immunother; 2020 Oct; 69(10):1973-1987. PubMed ID: 32388677 [TBL] [Abstract][Full Text] [Related]
3. Tumor-derived LIF promotes chemoresistance via activating tumor-associated macrophages in gastric cancers. Yu S; Li Q; Wang Y; Cui Y; Yu Y; Li W; Liu F; Liu T Exp Cell Res; 2021 Sep; 406(1):112734. PubMed ID: 34265288 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia Drives Dihydropyrimidine Dehydrogenase Expression in Macrophages and Confers Chemoresistance in Colorectal Cancer. Malier M; Gharzeddine K; Laverriere MH; Marsili S; Thomas F; Decaens T; Roth G; Millet A Cancer Res; 2021 Dec; 81(23):5963-5976. PubMed ID: 34645611 [TBL] [Abstract][Full Text] [Related]
5. GDF15 induces chemoresistance to oxaliplatin by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis in colorectal cancer. Lin H; Luo Y; Gong T; Fang H; Li H; Ye G; Zhang Y; Zhong M Cell Oncol (Dordr); 2024 Aug; 47(4):1149-1165. PubMed ID: 38386232 [TBL] [Abstract][Full Text] [Related]
6. Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of putrescine. Zhang X; Chen Y; Hao L; Hou A; Chen X; Li Y; Wang R; Luo P; Ruan Z; Ou J; Shi C; Miao H; Liang H Cancer Lett; 2016 Oct; 381(2):305-13. PubMed ID: 27514455 [TBL] [Abstract][Full Text] [Related]
7. The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6. Yin Y; Yao S; Hu Y; Feng Y; Li M; Bian Z; Zhang J; Qin Y; Qi X; Zhou L; Fei B; Zou J; Hua D; Huang Z Clin Cancer Res; 2017 Dec; 23(23):7375-7387. PubMed ID: 28928161 [No Abstract] [Full Text] [Related]
8. Hypoxia Induces Growth Differentiation Factor 15 to Promote the Metastasis of Colorectal Cancer via PERK-eIF2 Zheng H; Wu Y; Guo T; Liu F; Xu Y; Cai S Biomed Res Int; 2020; 2020():5958272. PubMed ID: 32076610 [TBL] [Abstract][Full Text] [Related]
9. 7 Su Y; Choi HS; Choi JH; Kim HS; Jang YS; Seo JW Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827121 [TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling. Liu C; Zhang W; Wang J; Si T; Xing W Cancer Sci; 2021 Oct; 112(10):4198-4207. PubMed ID: 34375482 [TBL] [Abstract][Full Text] [Related]
11. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10. Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999 [TBL] [Abstract][Full Text] [Related]
12. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179 [TBL] [Abstract][Full Text] [Related]
14. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells. Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841 [TBL] [Abstract][Full Text] [Related]
15. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells. Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278 [No Abstract] [Full Text] [Related]
16. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1. Liu X; Xie T; Mao X; Xue L; Chu X; Chen L Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5. Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524 [TBL] [Abstract][Full Text] [Related]
18. Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116. Kukcinaviciute E; Jonusiene V; Sasnauskiene A; Dabkeviciene D; Eidenaite E; Laurinavicius A J Cell Biochem; 2018 Jul; 119(7):5913-5920. PubMed ID: 29637602 [TBL] [Abstract][Full Text] [Related]
19. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells. Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084 [TBL] [Abstract][Full Text] [Related]
20. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]